Medical oncology (Northwood, London, England)

Keyphrases

Publications

volume 41, number 1, 2023

Samar A Dewidar, Omar Hamdy, Moetaza M Soliman, Amal M El Gayar, Mohamed El-Mesery
Enhanced therapeutic efficacy of doxorubicin/cyclophosphamide in combination with pitavastatin or simvastatin against breast cancer cells. Medical oncology (Northwood, London, England) 41 (1) (2023)
Ramya Devi Kt, M K Jaganathan, M R Ganesh, Karthick Dharshene
Chitosan-encapsulated naringenin promotes ROS mediated through the activation of executioner caspase-3. Medical oncology (Northwood, London, England) 41 (1) (2023)
Pradnya Gurav, Tanvi Patade, Shubham Hajare, Kedar R N
n-3 PUFAs synergistically enhance the efficacy of doxorubicin by inhibiting the proliferation and invasion of breast cancer cells. Medical oncology (Northwood, London, England) 41 (1) (2023)
Maurizio Capuozzo, Venere Celotto, Mariachiara Santorsola, Antonio Fabozzi, Loris Landi, Francesco Ferrara, Assunta Borzacchiello, Vincenza Granata, Francesco Sabbatino, Giovanni Savarese, Marco Cascella, Francesco Perri, Alessandro Ottaiano
Emerging treatment approaches for triple-negative breast cancer. Medical oncology (Northwood, London, England) 41 (1) (2023)
Maya Pankiw, Christine Brezden-Masley, George S Charames
Comprehensive genomic profiling for oncological advancements by precision medicine. Medical oncology (Northwood, London, England) 41 (1) (2023)
Buket Altinok Gunes, Tulin Ozkan, Nurbanu Gonulkirmaz, Asuman Sunguroglu
The evaluation of the anti-cancer effects of Anoectochilus roxburghii on hematological cancers in vitro. Medical oncology (Northwood, London, England) 41 (1) (2023)
Pradeep Velusamy, Sridhar Muthusami, Ramakrishnan Arumugam
In vitro evaluation of p-coumaric acid and naringin combination in human epidermoid carcinoma cell line (A431). Medical oncology (Northwood, London, England) 41 (1) (2023)

volume 40, number 8, 2023

Mei-Zhen Hu, Zhi-Zheng Dai, Hong-Yu Ji, An-Qi Zheng, Hang Liang, Mei-Mei Shen, Jun-Nan Liu, Kai-Fu Tang, Shu-Juan Zhu, Ke-Jian Wang
Upregulation of FAM50A promotes cancer development. Medical oncology (Northwood, London, England) 40 (8) (2023)
Qionghui Pan, Qingyu Wang, Tianshu Zhao, Xinyu Zhao, Yixin Liang, Mengyun Shi, Cong Chen, Feng Lin
FAK inhibitor PF-562271 inhibits the migration and proliferation of high-grade serous ovarian cancer cells through FAK and FAK mediated cell cycle arrest. Medical oncology (Northwood, London, England) 40 (8) (2023)
Deepa Mandal, Bikash Ranjan Sahu, Tithi Parija
Combination of tamoxifen and D-limonene enhances therapeutic efficacy in breast cancer cells. Medical oncology (Northwood, London, England) 40 (8) (2023)
Deepa Mandal, Bikash Ranjan Sahu, Tithi Parija
Combination of tamoxifen and D-limonene enhances therapeutic efficacy in breast cancer cells. Medical oncology (Northwood, London, England) 40 (8) (2023)
Deepa Mandal, Bikash Ranjan Sahu, Tithi Parija
Combination of tamoxifen and D-limonene enhances therapeutic efficacy in breast cancer cells. Medical oncology (Northwood, London, England) 40 (8) (2023)
Qionghui Pan, Qingyu Wang, Tianshu Zhao, Xinyu Zhao, Yixin Liang, Mengyun Shi, Cong Chen, Feng Lin
FAK inhibitor PF-562271 inhibits the migration and proliferation of high-grade serous ovarian cancer cells through FAK and FAK mediated cell cycle arrest. Medical oncology (Northwood, London, England) 40 (8) (2023)
Hongzhi Zhao, Liang Zhao, Lin Wu, Sheng Hu, Yangmei Huang, Wei Zhao
Hydrogen sulfide suppresses H 2 O 2 -induced proliferation and migration of HepG2 cells through Wnt/β-catenin signaling pathway. Medical oncology (Northwood, London, England) 40 (8) (2023)
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Valsala Gopalakrishnan Abilash, Rama Jayaraj, Ramkumar Katturajan, Sandra Kannampuzha, Reshma Murali, Arunraj Namachivayam, Sabina Evan Prince, Balachandar Vellingiri, Abhijit Dey, Kaviyarasi Renu
HPV-associated cancers: insights into the mechanistic scenario and latest updates. Medical oncology (Northwood, London, England) 40 (8) (2023)
Hongzhi Zhao, Liang Zhao, Lin Wu, Sheng Hu, Yangmei Huang, Wei Zhao
Hydrogen sulfide suppresses H 2 O 2 -induced proliferation and migration of HepG2 cells through Wnt/β-catenin signaling pathway. Medical oncology (Northwood, London, England) 40 (8) (2023)
Nadia Heydari, Mahsa Mahdizadeh, Seyyed Mehdi Jafari
The evolving landscape of involvement of DTYMK enzymes in cancer. Medical oncology (Northwood, London, England) 40 (8) (2023)
Nadia Heydari, Mahsa Mahdizadeh, Seyyed Mehdi Jafari
The evolving landscape of involvement of DTYMK enzymes in cancer. Medical oncology (Northwood, London, England) 40 (8) (2023)
Mei-Zhen Hu, Zhi-Zheng Dai, Hong-Yu Ji, An-Qi Zheng, Hang Liang, Mei-Mei Shen, Jun-Nan Liu, Kai-Fu Tang, Shu-Juan Zhu, Ke-Jian Wang
Upregulation of FAM50A promotes cancer development. Medical oncology (Northwood, London, England) 40 (8) (2023)
Qionghui Pan, Qingyu Wang, Tianshu Zhao, Xinyu Zhao, Yixin Liang, Mengyun Shi, Cong Chen, Feng Lin
FAK inhibitor PF-562271 inhibits the migration and proliferation of high-grade serous ovarian cancer cells through FAK and FAK mediated cell cycle arrest. Medical oncology (Northwood, London, England) 40 (8) (2023)

volume 40, number 9, 2023

Subhadra Kumari, Mandakini Singh, Santosh Kumar, Srinivasan Muthuswamy
SETD2 controls m6A modification of transcriptome and regulates the molecular oncogenesis of glioma. Medical oncology (Northwood, London, England) 40 (9) (2023)
Annette M Mathew, Zuliang Deng, Christian J Nelson, Trenton G Mayberry, Qian Bai, Marco Lequio, Emerson Fajardo, Huaping Xiao, Mark R Wakefield, Yujiang Fang
Artichoke as a melanoma growth inhibitor. Medical oncology (Northwood, London, England) 40 (9) (2023)
Mohaddeseh Hedayat, Mohammad Rafi Khezri, Reza Jafari, Hassan Malekinejad, Naime Majidi Zolbanin
Concomitant effects of paclitaxel and celecoxib on genes involved in apoptosis of triple-negative metastatic breast cancer cells. Medical oncology (Northwood, London, England) 40 (9) (2023)
Sana Abbasi, Helia Rivand, Fatemeh Eshaghi, Mohammad Amin Moosavi, Saeid Amanpour, Michael F McDermott, Marveh Rahmati
Inhibition of IRE1 RNase activity modulates tumor cell progression and enhances the response to chemotherapy in colorectal cancer. Medical oncology (Northwood, London, England) 40 (9) (2023)
Ziad Joha, Ayşegül Öztürk, Fatih Yulak, Özhan Karataş, Hilmi Ataseven
Mechanism of anticancer effect of gambogic acid on gastric signet ring cell carcinoma. Medical oncology (Northwood, London, England) 40 (9) (2023)
Xiangxiong Feng
Integrative analysis of GWAS and transcriptomics data reveal key genes for non-small lung cancer. Medical oncology (Northwood, London, England) 40 (9) (2023)
Preeti Dabas, Adithi Danda
Revolutionizing cancer treatment: a comprehensive review of CAR-T cell therapy. Medical oncology (Northwood, London, England) 40 (9) (2023)
Vahid Asghariazar, Mohammad Amini, Zahra Pirdel, Roghayeh Fekri, Asadollah Asadi, Kazem Nejati-Koshki, Behzad Baradaran, Yasin Panahi
The Schiff base hydrazine copper(II) complexes induce apoptosis by P53 overexpression and prevent cell migration through protease-independent pathways. Medical oncology (Northwood, London, England) 40 (9) (2023)
Wenqiang Liu, Ruhua Zhang, Xinhao Yu, Yu Zhang, Tiebang Kang, Dan Liao
CRISPR screen identifies GATAD1 as a synthetic lethal target with CDK4/6 inhibitors in estrogen receptor-positive breast cancer. Medical oncology (Northwood, London, England) 40 (9) (2023)
Anirban Goutam Mukherjee, Valsala Gopalakrishnan Abilash
The mechanistic insights of the antioxidant Keap1-Nrf2 pathway in oncogenesis: a deadly scenario. Medical oncology (Northwood, London, England) 40 (9) (2023)
Muli Xu, Jiankun Yu, Xiaoxiao Liu, Wanting Jia, Yu Duan, Di Ma, Jiaxuan Ma, Wanyang Lei, Xiaoxiao Liu
METTL3 regulatory TROAP can regulate the progression of non-small cell lung cancer through PI3K/AKT and EMT signaling pathway. Medical oncology (Northwood, London, England) 40 (9) (2023)
Fatemeh Heidari, Soheil Madadi, Neda Alizadeh, Mohammad Hossein Alimardani, Armin Safari, Mohammad Hossein Armand, Elahe Pishgahzadeh, Meysam Soleimani
The potential of monoclonal antibodies for colorectal cancer therapy. Medical oncology (Northwood, London, England) 40 (9) (2023)
Zhiqiang Sun, Tengfeng Yan, Hongxiang Jiang, Jiayang Cai, Xiwei Zhu, Qianxue Chen
Claudin-3 facilitates the progression and mediates the tumorigenic effects of TGF-β in glioblastoma multiforme. Medical oncology (Northwood, London, England) 40 (9) (2023)
Rajalakshmi Sabanayagam, Sneha Krishnamoorthy, Jayapradha Gnanagurusamy, Bharathi Muruganatham, Sridhar Muthusami
EGCG attenuate EGF triggered matrix abundance and migration in HPV positive and HPV negative cervical cancer cells. Medical oncology (Northwood, London, England) 40 (9) (2023)
Sandra Kannampuzha, Valsala Gopalakrishnan Abilash
Cancer chemoresistance and its mechanisms: Associated molecular factors and its regulatory role. Medical oncology (Northwood, London, England) 40 (9) (2023)
Fatih Altintas, Melek Tunc-Ata, Mucahit Secme, Vural Kucukatay
The anticancer effects of thymol on HepG2 cell line. Medical oncology (Northwood, London, England) 40 (9) (2023)
Lu Zhang, Zhi Li, Meng Zhang, Huangren Zou, Yuke Bai, Yanlin Liu, Juan Lv, Ling Lv, Pengjie Liu, Zhiyong Deng, Chao Liu
Advances in the molecular mechanism and targeted therapy of radioactive-iodine refractory differentiated thyroid cancer. Medical oncology (Northwood, London, England) 40 (9) (2023)
Farzaneh Karimi, Omid Azadbakht, Ali Veisi, Mohammad Sabaghan, Maryam Owjfard, Ebrahim Kharazinejad, Negar Dinarvand
Liquid biopsy in ovarian cancer: advantages and limitations for prognosis and diagnosis. Medical oncology (Northwood, London, England) 40 (9) (2023)
Muhammad Tufail
HOTAIR in colorectal cancer: structure, function, and therapeutic potential. Medical oncology (Northwood, London, England) 40 (9) (2023)
Haitao Zhu, Chunzhuo Song, Junjun Li, Qianfan Liu, Meng Liu, Liyue Fu
LHPP suppresses proliferation, migration, and invasion in hepatocellular carcinoma and pancreatic cancer by inhibiting EGFR signaling pathway. Medical oncology (Northwood, London, England) 40 (9) (2023)
Shu Tan, Hao Yu, Ye Xu, Yue Zhao, Ge Lou
Hypoxia-induced PPFIA4 accelerates the progression of ovarian cancer through glucose metabolic reprogramming. Medical oncology (Northwood, London, England) 40 (9) (2023)
Peifang Qin, Haitao Huang, Jiahui Wang, Tingting Jiang, Nannan Zeng, Qi Wang, Yulin He, Yali Zhou
The mechanism of LSM2 in the progression of live hepatocellular carcinoma was analyzed based on bioinformatics. Medical oncology (Northwood, London, England) 40 (9) (2023)
Daoan Cheng, Banglu Wang, Lige Wu, Rui Chen, Weiqing Zhao, Cheng Fang, Mei Ji
Exosomal non-coding RNAs-mediated EGFR-TKIs resistance in NSCLC with EGFR mutation. Medical oncology (Northwood, London, England) 40 (9) (2023)
Fatemeh Ghorbanzadeh, Davoud Jafari-Gharabaghlou, Mohammad Reza Dashti, Mehrdad Hashemi, Nosratollah Zarghami
Advanced nano-therapeutic delivery of metformin: potential anti-cancer effect against human colon cancer cells through inhibition of GPR75 expression. Medical oncology (Northwood, London, England) 40 (9) (2023)
Yirong Jiang, Jingwei Yao, Zhuoxin Yao, Yueting Huang, Zhangkun Li, Ziying Fan, Yong Zhou, Guowei Li, Zhifeng Li, Bing Xu
CD4 T cells in chronic myeloid leukemia present MHC class II-dependent and IFN-γ-dependent cytotoxic capacity. Medical oncology (Northwood, London, England) 40 (9) (2023)
Wenwei Yang, Yaru Niu, Yong-Kun Sun
Current neoadjuvant therapy for operable locally advanced esophageal cancer. Medical oncology (Northwood, London, England) 40 (9) (2023)
Lin-Lin Wang, Ruo-Tong Li, Zi-Heng Zang, Yun-Xuan Song, Yu-Zhe Zhang, Teng-Fei Zhang, Feng-Ze Wang, Gang-Ping Hao, Lu Cao
6-Methoxydihydrosanguinarine exhibits cytotoxicity and sensitizes TRAIL-induced apoptosis of hepatocellular carcinoma cells through ROS-mediated upregulation of DR5. Medical oncology (Northwood, London, England) 40 (9) (2023)
Hashem O Alsaab, Atiah H Almalki
Anti-HSP70 alleviates cell migration and proliferation in colorectal cancer cells (CRC) by targeting CXCR4 (in vitro study). Medical oncology (Northwood, London, England) 40 (9) (2023)
Wenbin Liu, Zhiguo Xie, Kefeng Shen, Lizhu Jiang, Chongyan Liu, Yongsheng Ge, Jihai Yu, Weidong Jia, Jinliang Ma, Hao Chen
Analysis of the safety and effectiveness of TACE combined with targeted immunotherapy in the treatment of intermediate and advanced hepatocellular carcinoma. Medical oncology (Northwood, London, England) 40 (9) (2023)
Dilay Karademir, Aykut Özgür
Small molecule heat shock protein 27 inhibitor J2 decreases ovarian cancer cell proliferation via induction of apoptotic pathways. Medical oncology (Northwood, London, England) 40 (9) (2023)